Pfizer has become the first pharmaceutical company to ask the U.S. Food and Drug Administration for full approval of its COVID-19 vaccine.
Like the Moderna and Johnson & Johnson vaccines, Pfizer’s COVID-19 shot is currently being administered under emergency use authorization. [TRENDING: Track uncertain path of rocket falling to Earth | Video: Man steals 2 police cruisers | Mom who gave birth on flight didn’t know she was prego] The company said it has already distributed 170 million doses of its vaccine, which is enough to vaccinate half that number of people.
Pfizer and BioNTech asked the FDA for priority review, a process that takes six months after the agency receives all pre-clinical and clinical trial data.